Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("gpl20")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 25

  • Page / 1
Export

Selection :

  • and

Entry Coreceptor Use and Fusion Inhibitor T20 Sensitivity of Dual-Tropic R5X4 HIV-1 in Primary Macrophage InfectionYANJIE YI; LOFTIN, Lamorris; LINGSHU WANG et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 3, pp 285-292, issn 1525-4135, 8 p.Article

Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitationLEDEBOER, Annemarie; SLOANE, Evan M; MILLIGAN, Erin D et al.Pain (Amsterdam). 2005, Vol 115, Num 1-2, pp 71-83, issn 0304-3959, 13 p.Article

A multivalent HIV-vaccine : development of a plasmid DNA for the expression of HIV envelope glycoproteins with hypervariable V3-loop domainsSCHILLING, R; HEIL, A; LANGNER, K et al.Vaccine. 2006, Vol 24, Num 21, pp 4648-4650, issn 0264-410X, 3 p.Article

Estrogenic protection against gpl20 neurotoxicity : Role of microgliaZEMLYAK, Ilona; BROOKE, Sheila; SAPOLSKY, Robert et al.Brain research. 2005, Vol 1046, Num 1-2, pp 130-136, issn 0006-8993, 7 p.Article

Novel approaches for identification of broadly cross-reactive HIV-1 neutralizing human monoclonal antibodies and improvement of their potencyZHANG, Mei-Yun; DIMITROV, Dimiter S.Current pharmaceutical design. 2007, Vol 13, Num 2, pp 203-212, issn 1381-6128, 10 p.Article

The utility of ISCOMATRIX™ adjuvant for dose reduction of antigen for vaccines requiring antibody responsesBOYLE, Jeff; EASTMAN, Donna; MILLAR, Christine et al.Vaccine. 2007, Vol 25, Num 14, pp 2541-2544, issn 0264-410X, 4 p.Article

Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteersGOEPFERT, Paul A; TOMARAS, Georgia D; MCELRATH, M. Juliana et al.Vaccine. 2007, Vol 25, Num 3, pp 510-518, issn 0264-410X, 9 p.Article

gp120-independent HIV infection of cells derived from the female reproductive tract, brain, and colonJUNYING ZHENG; YIMING XIE; CHEN, Irvin S. Y et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 2, pp 127-136, issn 1525-4135, 10 p.Article

Chemokine receptor-5 (CCR5) is a receptor for the HIV entry inhibitor peptide T (DAPTA)POLIANOVA, Maria T; RUSCETTI, Francis W; PERT, Candace B et al.Antiviral research. 2005, Vol 67, Num 2, pp 83-92, issn 0166-3542, 10 p.Article

Fusion of antigen to Fas-ligand in a DNA vaccine enhances immunogenicityNIMAL, Sonali; THOMAS, Mark S; HEATH, Andrew W et al.Vaccine. 2007, Vol 25, Num 12, pp 2306-2315, issn 0264-410X, 10 p.Article

Binding kinetics, uptake and intracellular accumulation of F105, an anti-gpl20 human IgG1κ monoclonal antibody, in HIV-1 infected cellsCLAYTON, Reginald; OHAGEN, Asa; GUTSHALL, Lester et al.Journal of virological methods. 2007, Vol 139, Num 1, pp 17-23, issn 0166-0934, 7 p.Article

Effects of SDF-1α and gp120IIIB on apoptotic pathways in SK-N-SH neuroblastoma cellsGEERAERTS, Thomas; DEIVA, Kumaran; M'SIKA, Ilana et al.Neuroscience letters. 2006, Vol 399, Num 1-2, pp 115-120, issn 0304-3940, 6 p.Article

Developments in HIV neuropathogenesisRUMBAUGH, Jeffrey A; NATH, Avindra.Current pharmaceutical design. 2006, Vol 12, Num 9, pp 1023-1044, issn 1381-6128, 22 p.Article

Engineering and functional evaluation of a single-chain antibody against HIV-1 external glycoprotein gp120WANG, H. W; COLE, D; JIANG, W. Z et al.Clinical and experimental immunology (Print). 2005, Vol 141, Num 1, pp 72-80, issn 0009-9104, 9 p.Article

Characteristics of the env Genes of HIV Type 1 Quasispecies in Long-Term Nonprogressors With Broadly Neutralizing AntibodiesBRAIBANT, Martine; AGUT, Henri; ROUZIOUX, Christine et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 3, pp 274-284, issn 1525-4135, 11 p.Article

Contribution of disulfide bonds in the carboxyl terminus of the human immunodeficiency virus type I gp120 glycoprotein to CD4 bindingLEKUTIS, C; OLSHEVSKY, U; FURMAN, C et al.Journal of acquired immune deficiency syndromes. 1992, Vol 5, Num 1, pp 78-81, issn 0894-9255Article

Gp120-mediated cytotoxicity of human brain microvascular endothelial cells is dependent on p38 mitogen-activated protein kinase activationNAVEED AHMED KHAN; DI CELLO, Francescopaolo; STINS, Monique et al.Journal of neurovirology. 2007, Vol 13, Num 3, pp 242-251, issn 1355-0284, 10 p.Article

Phenotypic studies on recombinant human immunodeficiency virus type 1 (HIV-1) containing CRF01_AE env gene derived from HIV-1-infected patient, residing in central ThailandUTACHEE, Pirapom; JINNOPAT, Piyamat; IKUTA, Kazuyoshi et al.Microbes and infection. 2009, Vol 11, Num 3, pp 334-343, issn 1286-4579, 10 p.Article

Neonatal intrahippocampal gp120 injection : An examination early in developmentFITTING, Sylvia; BOOZE, Rosemarie M; MACTUTUS, Charles F et al.Neurotoxicology (Park Forest South). 2007, Vol 28, Num 1, pp 101-107, issn 0161-813X, 7 p.Article

Maturing neurons are selectively sensitive to human immunodeficiency virus type 1 exposure in differentiating human neuroepithelial progenitor cell culturesMCCARTHY, Micheline; VIDAURRE, Iiving; GEFFIN, Rebeca et al.Journal of neurovirology. 2006, Vol 12, Num 5, pp 333-348, issn 1355-0284, 16 p.Article

Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cellsNAKAMUTA, Shinichi; ENDO, Hiroshi; HIGASHI, Youichiro et al.Journal of neurovirology. 2008, Vol 14, Num 3, pp 186-195, issn 1355-0284, 10 p.Article

Inhibition of HIV entry by carbohydrate-binding proteinsBALZARINI, J.Antiviral research. 2006, Vol 71, Num 2-3, pp 237-247, issn 0166-3542, 11 p.Article

HIV co-receptor inhibitors as novel class of anti-HIV drugsSCHOLS, Dominique.Antiviral research. 2006, Vol 71, Num 2-3, pp 216-226, issn 0166-3542, 11 p.Article

Conformational properties of HIV-1 gp120/V3 immunogenic domainsGALANAKIS, Petros A; SPYROULIAS, Georgios A; RIZOS, Apostolos et al.Current medicinal chemistry. 2005, Vol 12, Num 13, pp 1551-1568, issn 0929-8673, 18 p.Conference Paper

Tyrosine-sulfate isosteres of CCR5 N-terminus as tools for studying HIV-1 entryLAM, Son N; ACHARYA, Priyamvada; WYATT, Richard et al.Bioorganic & medicinal chemistry. 2008, Vol 16, Num 23, pp 10113-10120, issn 0968-0896, 8 p.Article

  • Page / 1